![Douglas Lind](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Lind
Presidente presso
TMune Therapeutics, Inc.
Profilo
Dr. Douglas D.
Lind, MD, is a Managing Director at Biomark Capital Management Co. LLC and a Co-President & Director at TMune Therapeutics, Inc. He is on the Board of Directors at TMune Therapeutics, Inc., HyperMed Imaging, Inc. and Lentigen Technology, Inc.
Dr. Lind was previously employed as an Independent Director by Enveric Biosciences, Inc., a Managing Director by Burrill & Co. LLC, an Analyst by Morgan Stanley & Co., Inc., a Research Analyst by PaineWebber, Inc., and a Managing Director by GBP Capital.
He also served on the board at Flexible Stenting Solutions, Inc., MabVax Therapeutics, Inc., Opus Bio, Inc., Spectral Image, Inc., Strand Life Sciences Pvt Ltd. and Viragen, Inc.
He received his graduate degree from the University of Iowa.
Posizioni attive di Douglas Lind
| Società | Posizione | Inizio |
|---|---|---|
TMune Therapeutics, Inc.
 TMune Therapeutics, Inc. BiotechnologyHealth Technology Provides cancer treatment research and technology development services | Presidente | - |
HyperMed Imaging, Inc.
 HyperMed Imaging, Inc. Medical SpecialtiesHealth Technology Manufactures medical imaging device | Direttore/Membro del Consiglio | - |
Biomark Capital Management Co. LLC
 Biomark Capital Management Co. LLC Investment ManagersFinance Biomark Capital invests in companies located in the United States primarily in North America, along with a specific focus in Russia, Taiwan, India and China. The firm targets companies operating in the fields of the therapeutics, medical devices, molecular diagnostics, healthcare delivery and information technology service sectors. It provides financing for early, mid and later stage capital transactions with an investment size of USD 5 - 10 million. | Investitore di Private Equity | 01/11/2013 |
Lentigen Technology, Inc.
 Lentigen Technology, Inc. BiotechnologyHealth Technology Provides biotechnology services | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Douglas Lind
| Società | Posizione | Fine |
|---|---|---|
Burrill LLC
 Burrill LLC Investment ManagersFinance Burrill invests in companies located in the United States. The firm focuses on a broad range of sectors. It participates in buyout and early-stage transactions. | Investitore di Private Equity | 31/10/2013 |
Viragen, Inc.
 Viragen, Inc. BiotechnologyHealth Technology Develops and researches immunological products | Direttore/Membro del Consiglio | 01/02/2005 |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 24/01/2002 |
PaineWebber, Inc.
 PaineWebber, Inc. Investment Banks/BrokersFinance Provides stock brokerage and asset management services | Corporate Officer/Principal | 31/12/1996 |
| ENVERIC BIOSCIENCES, INC. | Direttore/Membro del Consiglio | - |
Formazione di Douglas Lind
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
92
Relazioni di 1° grado
16
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 16 |
|---|---|
Viragen, Inc.
Viragen, Inc. BiotechnologyHealth Technology Develops and researches immunological products | Health Technology |
MabVax Therapeutics, Inc.
 MabVax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Developed and commercialized immunotherapeutics for the treatment of cancer | Health Technology |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Burrill LLC
Burrill LLC Investment ManagersFinance Burrill invests in companies located in the United States. The firm focuses on a broad range of sectors. It participates in buyout and early-stage transactions. | Finance |
PaineWebber, Inc.
PaineWebber, Inc. Investment Banks/BrokersFinance Provides stock brokerage and asset management services | Finance |
University of Iowa
 University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Opus Bio, Inc.
 Opus Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures lentiviral gene delivery technologies | Commercial Services |
Strand Life Sciences Pvt Ltd.
 Strand Life Sciences Pvt Ltd. Packaged SoftwareTechnology Services Develops bioinformatics and clinical diagnostic software | Technology Services |
GBP Capital
 GBP Capital Investment ManagersFinance GBP Capital provides venture funding and assistance to early and mid-stage life science companies. They target companies with unique approaches to diagnostics, therapeutics and medical devices. GBP Capital focuses on investing in companies with technologies that leverage and build upon medical breakthroughs, as well as other major developments taking place within the life-sciences industry. | Finance |
Spectral Image, Inc.
 Spectral Image, Inc. Medical SpecialtiesHealth Technology Develops imaging technology for biomedical use | Health Technology |
Flexible Stenting Solutions, Inc.
 Flexible Stenting Solutions, Inc. Medical/Nursing ServicesHealth Services Develops third-generation flexible peripheral arterial, venous, neurovascular and biliary stents | Health Services |
TMune Therapeutics, Inc.
TMune Therapeutics, Inc. BiotechnologyHealth Technology Provides cancer treatment research and technology development services | Health Technology |
HyperMed Imaging, Inc.
HyperMed Imaging, Inc. Medical SpecialtiesHealth Technology Manufactures medical imaging device | Health Technology |
Biomark Capital Management Co. LLC
Biomark Capital Management Co. LLC Investment ManagersFinance Biomark Capital invests in companies located in the United States primarily in North America, along with a specific focus in Russia, Taiwan, India and China. The firm targets companies operating in the fields of the therapeutics, medical devices, molecular diagnostics, healthcare delivery and information technology service sectors. It provides financing for early, mid and later stage capital transactions with an investment size of USD 5 - 10 million. | Finance |
Lentigen Technology, Inc.
Lentigen Technology, Inc. BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
Enveric Biosciences, Inc.
 Enveric Biosciences, Inc. Pharmaceuticals: OtherHealth Technology Develops cannabinoid medicines and combination therapies | Health Technology |
